We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

33 hedge funds and large institutions have $6.68M invested in Tempest Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 9 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% less capital invested

Capital invested by funds: $7.97M → $6.68M (-$1.29M)

20% less funds holding

Funds holding: 41 → 33 (-8)

56% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 9

80% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 10

Holders
33
Holders Change
-8
Holders Change %
-19.51%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
9
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$364K
2
PAM
Panagora Asset Management
Massachusetts
+$31.6K
3
Two Sigma Investments
Two Sigma Investments
New York
+$31.6K
4
TRCT
Tower Research Capital (TRC)
New York
+$13.2K
5
Morgan Stanley
Morgan Stanley
New York
+$2.63K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$458K
2
BC
Broadfin Capital
New York
-$442K
3
Wells Fargo
Wells Fargo
California
-$387K
4
TS
Third Security
Virginia
-$303K
5
Franklin Resources
Franklin Resources
California
-$290K
Name Holding Trade Value Shares
Change 		Change in
Stake
EAM
26
Eagle Asset Management
Florida
$9K – – –
Morgan Stanley
27
Morgan Stanley
New York
$7K +$2.63K +1 +50%
MAM
28
Meeder Asset Management
Ohio
$5.55K – – –
TIM
29
Tortoise Investment Management
New York
$3K – – –
Federated Hermes
30
Federated Hermes
Pennsylvania
$2K – – –
JP Morgan Chase
31
JP Morgan Chase
New York
$2K – – –
Bank of America
32
Bank of America
North Carolina
$1K – – –
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$1K – – –
BWM
34
Baystate Wealth Management
Massachusetts
$1K – – –
Citigroup
35
Citigroup
New York
$1K – – –
TCOV
36
Trust Company of Vermont
Vermont
$1K – – –
UBS Group
37
UBS Group
Switzerland
$1K – – –
RE
38
RBC Europe
United Kingdom
$91 – – –
BC
39
Broadfin Capital
New York
– -$442K -186 Closed
TS
40
Third Security
Virginia
– -$303K -128 Closed
Franklin Resources
41
Franklin Resources
California
– -$290K -122 Closed
AIC
42
AWM Investment Company
New York
– -$122K -51 Closed
DMK
43
David M. Knott
– -$91K -38 Closed
Millennium Management
44
Millennium Management
New York
– -$67K -28 Closed
Citadel Advisors
45
Citadel Advisors
Florida
– -$33K -14 Closed
WS
46
Wedbush Securities
California
– -$34K -14 Closed
Russell Investments Group
47
Russell Investments Group
United Kingdom
– -$22K -9 Closed
GC
48
Guggenheim Capital
Illinois
– -$9K -4 Closed
1
2

TPST Hedge Fund Activity: Q2 2018 in Review

33 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q2 2018, worth a combined $6.68M — down 16% from $7.97M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TPST and 2 opened new positions — a net loss of 8 holders — while 9 trimmed existing stakes and 4 added.

The largest buyer was Renaissance Technologies, adding an estimated $364K. The largest seller was Sabby Management, cutting an estimated $458K.

  • 33 institutional investors held Tempest Therapeutics (TPST) as of Q2 2018, down from 41 in Q1 2018.
  • Funds reported $6.68M of Tempest Therapeutics stock for Q2 2018, down 16% quarter-over-quarter.
  • 2 funds opened new Tempest Therapeutics positions in Q2 2018 and 10 closed out, a net change of -8 holders.
  • The largest Tempest Therapeutics buyer in Q2 2018 was Renaissance Technologies, an estimated $364K added.
  • The largest Tempest Therapeutics seller in Q2 2018 was Sabby Management, an estimated $458K sold.

Based on aggregated 13F filings for Q2 2018.